These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 20192727)

  • 21. Microscopic observation drug susceptibility assay in the diagnosis of multidrug-resistant tuberculosis.
    Rasslan O; Hafez SF; Hashem M; Ahmed OI; Faramawy MA; Khater WS; Saleh DA; Mohamed MI; Khalifa MA; Shoukry FA; El-Moghazy EH
    Int J Tuberc Lung Dis; 2012 Jul; 16(7):941-6. PubMed ID: 22584201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-Effectiveness of isoniazid preventive therapy among HIV-infected patients clinicaly screened for latent tuberculosis infection in Dar es Salaam, Tanzania: A prospective Cohort study.
    Shayo GA; Chitama D; Moshiro C; Aboud S; Bakari M; Mugusi F
    BMC Public Health; 2017 Jul; 18(1):35. PubMed ID: 28724374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study.
    Lawn SD; Brooks SV; Kranzer K; Nicol MP; Whitelaw A; Vogt M; Bekker LG; Wood R
    PLoS Med; 2011 Jul; 8(7):e1001067. PubMed ID: 21818180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of microscopic observation drug susceptibility for drug susceptibility testing of mycobacterium tuberculosis in smear-positive sputum].
    Lu JM; Wang J; Huang XC; Hu ZY; Cui ZL
    Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Jan; 45(1):21-5. PubMed ID: 21418814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study.
    Scott LE; McCarthy K; Gous N; Nduna M; Van Rie A; Sanne I; Venter WF; Duse A; Stevens W
    PLoS Med; 2011 Jul; 8(7):e1001061. PubMed ID: 21814495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis of pulmonary tuberculosis in HIV-positive patients by microscopic observation drug susceptibility assay.
    Ha DT; Lan NT; Kiet VS; Wolbers M; Hang HT; Day J; Hien NQ; Tien NA; An PT; Anh TT; Oanh do TT; Hoa CL; Chau NT; Hai NN; Binh NT; Ngoc le H; Phuong DT; Quyet TV; Tuyen NT; Ha VT; Nho NT; Hoa DV; Anh PT; Dung NH; Farrar J; Caws M
    J Clin Microbiol; 2010 Dec; 48(12):4573-9. PubMed ID: 20926704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tuberculosis drug resistance and outcomes among tuberculosis inpatients in Lilongwe, Malawi.
    Vorkas C; Kayira D; van der Horst C; Hoffman I; Hosseinipour M; Kanyemba C; Nguluwe N; Chikaonda T; Kalikhoka M; Kalaundi D; Namarika D; Gilligan P; Krysiak R
    Malawi Med J; 2012 Jun; 24(2):21-4. PubMed ID: 23638265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preventing tuberculosis among HIV-infected pregnant women in Lesotho: the case for rolling out active case finding and isoniazid preventive therapy.
    Tiam A; Machekano R; Gounder CR; Maama-Maime LB; Ntene-Sealiete K; Sahu M; Isavwa A; Oyebanji O; Ahimbisibwe A; Mokone M; Barnes GL; Chaisson RE; Guay L; Kassaye S
    J Acquir Immune Defic Syndr; 2014 Sep; 67(1):e5-e11. PubMed ID: 25118796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microscopic-observation drug susceptibility assay provides rapid and reliable identification of MDR-TB.
    Ejigu GS; Woldeamanuel Y; Shah NS; Gebyehu M; Selassie A; Lemma E
    Int J Tuberc Lung Dis; 2008 Mar; 12(3):332-7. PubMed ID: 18284841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct nitrate reductase assay versus microscopic observation drug susceptibility test for rapid detection of MDR-TB in Uganda.
    Bwanga F; Haile M; Joloba ML; Ochom E; Hoffner S
    PLoS One; 2011 May; 6(5):e19565. PubMed ID: 21573015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of multidrug resistance in Mycobacterium tuberculosis isolates from HIV seropositive and seronegative patients with pulmonary tuberculosis in north India.
    Sethi S; Mewara A; Dhatwalia SK; Singh H; Yadav R; Singh K; Gupta D; Wanchu A; Sharma M
    BMC Infect Dis; 2013 Mar; 13():137. PubMed ID: 23497169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening for active tuberculosis before isoniazid preventive therapy among HIV-infected West African adults.
    Moh R; Badjé A; N'takpé JB; Kouamé GM; Gabillard D; Ouassa T; Ouattara E; Le Carrou J; Bohoussou F; Messou E; Eholié S; Anglaret X; Danel C
    Int J Tuberc Lung Dis; 2017 Dec; 21(12):1237-1244. PubMed ID: 29297443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic accuracy of the microscopic observation drug susceptibility assay: a pilot study from India.
    Michael JS; Daley P; Kalaiselvan S; Latha A; Vijayakumar J; Mathai D; John KR; Pai M
    Int J Tuberc Lung Dis; 2010 Apr; 14(4):482-8. PubMed ID: 20202307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of the Three I's for HIV/TB and ART to prevent TB among people living with HIV.
    Gupta S; Abimbola T; Date A; Suthar AB; Bennett R; Sangrujee N; Granich R
    Int J Tuberc Lung Dis; 2014 Oct; 18(10):1159-65. PubMed ID: 25216828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Benefits of continuous isoniazid preventive therapy may outweigh resistance risks in a declining tuberculosis/HIV coepidemic.
    Kunkel A; Crawford FW; Shepherd J; Cohen T
    AIDS; 2016 Nov; 30(17):2715-2723. PubMed ID: 27782966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of two line probe assays for rapid detection of Mycobacterium tuberculosis, tuberculosis (TB) drug resistance, and non-TB Mycobacteria in HIV-infected individuals with suspected TB.
    Luetkemeyer AF; Kendall MA; Wu X; Lourenço MC; Jentsch U; Swindells S; Qasba SS; Sanchez J; Havlir DV; Grinsztejn B; Sanne IM; Firnhaber C;
    J Clin Microbiol; 2014 Apr; 52(4):1052-9. PubMed ID: 24430455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis.
    Brady MF; Coronel J; Gilman RH; Moore DA
    J Vis Exp; 2008 Aug; (17):. PubMed ID: 19066507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the performance of the microscopic observation drug susceptibility assay for diagnosis of extrapulmonary tuberculosis in China: A preliminary study.
    Huang Z; Xiong G; Luo Q; Jiang B; Li W; Xu X; Li J
    Respirology; 2014 Jan; 19(1):132-7. PubMed ID: 24103019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expanding the role of the microscopic observation drug susceptibility assay in tuberculosis and HIV management.
    Minion J; Pai M
    Clin Infect Dis; 2010 Apr; 50(7):997-9. PubMed ID: 20192726
    [No Abstract]   [Full Text] [Related]  

  • 40. MODS-Wayne, a Colorimetric Adaptation of the Microscopic-Observation Drug Susceptibility (MODS) Assay for Detection of
    Alcántara R; Fuentes P; Antiparra R; Santos M; Gilman RH; Kirwan DE; Zimic M; Sheen P
    J Clin Microbiol; 2019 Feb; 57(2):. PubMed ID: 30429257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.